Category: Jurisdictions
-
Some direct patent infringement âacceptable priceâ for expediting competition:Â U.S. Solicitor General urges Supreme Court to review skinny labeling and generic drug access
United States Solicitor General D. John Sauer has filed a petition urging the Supreme Court to intervene in a long-running drug patent infringement case in which he alleges the Federal Circuit failed to apply the âskinny labellingâ (section viii) pathway, which allows the entry of generics that carve out patented uses but otherwise duplicate the…
-
Optical fibre cable makerâs invalidation claims were âvaliantâ but âfell flatâ, EWHC rules in Fujikura v. Sterlite patent infringement decision
The High Court of Justice for England & Wales has ruled that a patent asserted by Japanese electrical equipment manufacturer Fujikura is valid and has been infringed by a range of Indian rival Sterliteâs fiber optic cables.
-
Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successor
On Thursday, Halozyme obtained a preliminary injunction against Merck’s Keytruda SC.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
The UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
USPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
-
InterDigital’s jurisdictional challenge to Amazon’s UK claims heard by skeptical judge; Amazon rejects LJ Arnold’s arbitration idea
The hurdle to get standalone FRAND claims in the UK dismissed for jurisdicitonal reasons appears to remain very high, if not insurmountable.
-
Delhi High Court allows Dr. Reddyâs to enter Indian semaglutide market in March 2026, dismisses Novo Nordisk appeal
In a landmark judgment, the Delhi High Court has ruled that Novo Nordisk failed to prove why it should be granted an interim injunction against Dr. Reddyâs, but has ordered the latter not to proceed with sales in Indian until the patent-in-suit expires on March 20, 2026.
-
Infineon handed preliminary win in ITC patent infringement dispute against InnoscienceÂ
The United States International Trade Commission has issued a final initial determination finding that one of two gallium nitride patents that Infineon asserted against Chinese rival Innoscience has been infringed.
-
USPTO upholds core Proxense patent in Samsung, Apple, Microsoft, Google invalidation cases
Biometrics firm Proxense has bagged a key win in ongoing big tech patent litigation, after the United States Patent & Trademark Office upheld a key patent following a review requested by Samsung.
-
Xiaomi to face off with Datang over 4G/5G SEP infringement in Munich in March 2026, successfully invalidates ASC patents in China
The Munich I Regional Court will hear Datangâs SEP infringement suit against Xiaomi on March 11, 2025, while the latter has successfully invalidated three of Advanced Standard Communication LLCâs patents in China.